IDEXX Labs (IDXX) Tops Q2 EPS by 12c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Northcoast Research Upgrades IDEXX Laboratories (IDXX) to Neutral
August 3, 2016 9:32 AM EDTNorthcoast Research upgraded IDEXX Laboratories (NASDAQ: IDXX) from Sell to Neutral.
For an analyst ratings summary and ratings history on IDEXX Laboratories click here. For more ratings news on IDEXX Laboratories click here.
Shares of IDEXX Laboratories closed at $105.88 yesterday.
... MoreIDEXX Laboratories (IDXX) PT Raised to $120 at Stifel on 'Very Impressive' Q2
August 2, 2016 1:26 PM EDTStifel Buy analyst Jonathan Block reiterated a Buy rating and raised his price target on IDEXX Laboratories (NASDAQ: IDXX) to $120.00 (from $92.00) following "very impressive" 2Q16 results with revenue of $467MM and EPS of $0.74, well above our $447MM and $0.61 estimates.
Block commented, "Management raised 2016... More
